The effect of bladder function on the efficacy of transurethral prostatectomy in patients with benign prostatic hyperplasia: a retrospective, single-center study

We investigated the impact and predictive value of bladder function in patients with benign prostatic hyperplasia (BPH) on the efficacy of transurethral prostatectomy. Symptomatic, imaging, and urodynamic data of patients who underwent transurethral prostatectomy at West China Hospital of Sichuan University (Chengdu, China) from July 2019 to December 2021 were collected. Follow-up data included the quality of life (QoL), International Prostate Symptom Score (IPSS), and IPSS storage and voiding (IPSS-s and IPSS-v). Moreover, urinary creatinine (Cr), nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and prostaglandin estradiol (PGE2) were measured in 30 patients with BPH and 30 healthy participants. Perioperative indicators were determined by subgroup analyses and receiver operating characteristic (ROC) curve analysis. Among the 313 patients with BPH included, patients with severe micturition problems had more improvements but higher micturition grades postoperatively than those with moderate symptoms. Similarly, good bladder sensation, compliance, and detrusor contractility (DC) were predictors of low postoperative IPSS and QoL. The urinary concentrations of BDNF/Cr, NGF/Cr, and PGE2/Cr in patients were significantly higher than those in healthy participants (all P < 0.001). After evaluation, only DC was significantly related to both urinary indicators and postoperative recovery of patients. Patients with good DC, as predicted by urinary indicators, had lower IPSS and IPSS-v than those with reduced DC at the 1st month postoperatively (both P < 0.05). In summary, patients with impaired bladder function had poor recovery. The combined levels of urinary BDNF/Cr, NGF/Cr, and PGE2/Cr in patients with BPH may be valid predictors of preoperative bladder function and postoperative recovery.

[1]  Yan-bo Chen,et al.  Better timing for HoLEP: a retrospective analysis of patients treated with HoLEP over a 10-year period with a 1-year follow-up , 2022, Asian journal of andrology.

[2]  T. Wilt,et al.  Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART II—Surgical Evaluation and Treatment , 2021, The Journal of urology.

[3]  A. Apostolidis,et al.  The use of urinary biomarkers in the diagnosis of overactive bladder in female patients. A systematic review and meta-analysis , 2021, International Urogynecology Journal.

[4]  S. Xia,et al.  A novel mouse model simulating transurethral laser vaporization prostatectomy , 2021, Asian journal of andrology.

[5]  A. Hossain,et al.  Effects of Transurethral Resection of Prostate (TURP) on Quality of Life in Case of Benign Prostatic Hyperplasia , 2019, Journal of National Institute of Neurosciences Bangladesh.

[6]  D. Tincello,et al.  Methods of assessing and recording bladder sensation: a review of the literature , 2018, International Urogynecology Journal.

[7]  T. Eddinger.  Reversible plasticity of detrusor smooth muscle: evidence for a key role of "slipping" actomyosin cross-bridges in the control of urinary bladder compliance. , 2017, American journal of physiology. Renal physiology.

[8]  R. Sinha,et al.  Does prostate size predict the urodynamic characteristics and clinical outcomes in benign prostate hyperplasia? , 2017, Urology annals.

[9]  J. Blaivas,et al.  Surgical treatment of detrusor underactivity: a short term proof of concept study , 2017, International braz j urol : official journal of the Brazilian Society of Urology.

[10]  G. Vijaya,et al.  Reliability and validity of urinary nerve growth factor measurement in women with lower urinary tract symptoms , 2016, Neurourology and urodynamics.

[11]  Wei Yu,et al.  Impact of Changing Trends in Medical Therapy on Transurethral Resection of the Prostate: Two Decades of Change in China. , 2016, Urology.

[12]  Seung-June Oh,et al.  Impact of Detrusor Underactivity on Surgical Outcomes of Laser Prostatectomy: Comparison in Serial 12-Month Follow-Up Outcomes Between Potassium-Titanyl-Phosphate Photoselective Vaporization of the Prostate (PVP) and Holmium Laser Enucleation of the Prostate (HoLEP). , 2016, Urology.

[13]  S. Horie,et al.  The Impact of Increased Bladder Blood Flow on Storage Symptoms after Holmium Laser Enucleation of the Prostate , 2015, PloS one.

[14]  Seung-June Oh,et al.  Non-Invasive Clinical Parameters for the Prediction of Urodynamic Bladder Outlet Obstruction: Analysis Using Causal Bayesian Networks , 2014, PloS one.

[15]  C. Cruz.  Neurotrophins in bladder function: What do we know and where do we go from here? , 2014, Neurourology and urodynamics.

[16]  C. Liao,et al.  Diagnostic value of International Prostate Symptom Score voiding‐to‐storage subscore ratio in male lower urinary tract symptoms , 2011, International journal of clinical practice.

[17]  G. Somogyi,et al.  Overactive and underactive bladder dysfunction is reflected by alterations in urothelial ATP and NO release , 2011, Neurochemistry International.

[18]  S. Naito,et al.  Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction , 2009, Neurourology and Urodynamics.

[19]  C. Agrawal,et al.  Change in urinary symptoms and quality of life in men with benign prostatic hyperplasia after transurethral resection of prostate. , 2007, Nepal Medical College journal : NMCJ.

[20]  C. Kwak,et al.  Influence of bladder contractility on short-term outcomes of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate. , 2007, Urology.

[21]  A. Nagai,et al.  Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder , 2007, Neurourology and urodynamics.

[22]  N. Masumori,et al.  Is the short‐term outcome of transurethral resection of the prostate affected by preoperative degree of bladder outlet obstruction, status of detrusor contractility or detrusor overactivity? , 2006, International journal of urology : official journal of the Japanese Urological Association.

[23]  Song Bo,et al.  Effect of bladder outlet obstruction on detrusor smooth muscle cell: an in vitro study. , 2003, The Journal of surgical research.

[24]  P. Abrams,et al.  Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function , 1999, BJU international.

[25]  L. Bih,et al.  Bladder shape impact on the accuracy of ultrasonic estimation of bladder volume. , 1998, Archives of physical medicine and rehabilitation.

[26]  A Semjonow,et al.  Prostate-specific antigen corrected for prostate volume improves differentiation of benign prostatic hyperplasia and organ-confined prostatic cancer. , 1994, British journal of urology.

[27]  T. Kluz,et al.  Novel biomarkers of overactive bladder syndrome. , 2017, Ginekologia polska.

[28]  P. Abrams,et al.  The Abrams-Griffiths nomogram , 2004, World Journal of Urology.

[29]  L. Håheim,et al.  Accuracy and repeatability of prostate volume measurements by transrectal ultrasound , 2002, Prostate Cancer and Prostatic Diseases.

[30]  P. Abrams,et al.  Good urodynamic practices: Uroflowmetry, filling cystometry, and pressure‐flow studies * * , 2002, Neurourology and urodynamics.

[31]  T. Boon,et al.  Urethral resistance factor (URA) versus Schäfer's obstruction grade and abrams–griffiths (AG) number in the diagnosis of obstructive benign prostatic hyperplasia , 2001, Neurourology and urodynamics.

[32]  S. Il Seo,et al.  Changes in detrusor and urinary growth factors according to detrusor function after partial bladder outlet obstruction in the rat. , 2001, Urology.